TY  - JOUR
PY  - 2000//
TI  - Use of venlafaxine in children and adolescents: a review of current literature
JO  - Depression and anxiety
A1  - Weller, E. B.
A1  - Weller, R. A.
A1  - Davis, G. P.
SP  - 85
EP  - 89
VL  - 12
IS  - Suppl 1
N2  - Pediatric psychopharmacology is hindered by the relative lack of controlled, empirical clinical trials [Shatzberg and Nemeroff, 1998: Washington, D.C.: The American Psychiatric Press, Inc. p 301-306]. Psychiatric disorders in children and adolescents carry considerable morbidity, impede development, and carry a significant mortality by suicide. Therefore, there is a need for studies of antidepressants and other psychotropics in children and adolescents. This article reviews the preliminary evidence that venlafaxine (Effexor), a novel antidepressant, may be useful in children and adolescents with a variety of psychiatric disorders.<p /> <p>Language: en</p>
LA  - en
SN  - 1091-4269
UR  - http://dx.doi.org/10.1002/1520-6394(2000)12:1+<85::AID-DA12>3.0.CO;2-0
ID  - ref1
ER  -